SCHEMBL30593199

SCHEMBL30593199

Cc1cc(OCc2ccccc2)cc(-c2cnc(C(F)(F)F)cc2Oc2ccc(F)c(F)c2C)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC5 Q9UQL6 2/20 0.38
SYK P43405 1/20 0.35
KDM1A O60341 2/20 0.35
FFAR1 O14842 2/20 0.35
PTGER1 P34995 2/20 0.35
MRGPRX4 Q96LA9 2/20 0.34
MMP13 P45452 1/20 0.34
RAF1 P04049 2/20 0.34
BRAF P15056 2/20 0.34
PPARG P37231 1/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PDGFRB P09619 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26608480 1.00 HDAC1 (0.38) HDAC1HDAC8HDAC6HDAC5SYK
SCHEMBL26608475 0.81 HDAC1 (0.41) HDAC1HDAC8HDAC6HDAC5SYK
SCHEMBL31336252 0.81 HDAC1 (0.41) HDAC1HDAC8HDAC6HDAC5SYK
SCHEMBL26608377 0.78 L3MBTL1 (0.41) HDAC1HDAC8HDAC6HDAC5KDM1A
SCHEMBL30593187 0.73 HDAC1 (0.41) HDAC1HDAC8HDAC6HDAC5SYK
SCHEMBL26608380 0.73 HDAC1 (0.41) HDAC1HDAC8HDAC6HDAC5SYK
SCHEMBL26608374 0.72 CNR2 (0.36) HDAC1HDAC8HDAC6HDAC5SYK
SCHEMBL30593153 0.70 ALDH1A1 (0.43) HDAC1HDAC8HDAC6HDAC5MRGPRX4
SCHEMBL26608363 0.70 ALDH1A1 (0.43) HDAC1HDAC8HDAC6HDAC5MRGPRX4
SCHEMBL26608223 0.70 ALDH1A1 (0.43) HDAC1HDAC8HDAC6HDAC5MRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119546580-A Heteroaryl compounds for the treatment of pain 沃泰克斯药物股份有限公司 2025-02-28 CN disclosed
EP-4511115-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN Vertex Pharmaceuticals Incorporated (US) 2025-02-26 EP disclosed
WO-2023205468-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-26 WO disclosed